Kai Pinkernell

Kai Pinkernell

Company: Glycostem Therapeutics

Job title: CMO


Off-the-Shelf NK Cells in European AML Clinical Trial 3:30 pm

Phase I/II a clinical trial in AML ongoing in the EU First outcomes at low doses Upcoming geographical and indication expansionRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.